The National Institutes of Health this month awarded nearly $450,000 in funding to support two RNAi- and microRNA-related research projects, including one for the development of a low-cost oligonucleotide synthesizer and one studying the small, non-coding RNAs in cardiovascular health.

The first grant was awarded to Keith Anderson, the president of California-based startup Synthomics, to assist in the company’s development of an oligonucleotide synthesis technology designed to significantly lower production costs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.